Newsletter

Talking Points: 31 October 2022

Stakeholders emphasize the need to ensure final surprise medical billing rules protect consumers during the arbitration process; hospitals exploit a discount drug program to mark up life-saving drugs; Medicare Advantage plans spend less on low-value care than traditional Medicare; and, hundreds of healthcare organizations urge lawmakers to extend COVID telehealth flexibilities.

Last Week in Healthcare Reform: 10 October 2022

Stakeholders emphasize the need to ensure final surprise medical billing rules protect consumers during the arbitration process; hospitals exploit a discount drug program to mark up life-saving drugs; Medicare Advantage plans spend less on low-value care than traditional Medicare; and, hundreds of healthcare organizations urge lawmakers to extend COVID telehealth flexibilities.

Last Week in Healthcare Reform: 3 October 2022

Stakeholders emphasize the need to ensure final surprise medical billing rules protect consumers during the arbitration process; hospitals exploit a discount drug program to mark up life-saving drugs; Medicare Advantage plans spend less on low-value care than traditional Medicare; and, hundreds of healthcare organizations urge lawmakers to extend COVID telehealth flexibilities.

Last Week in Healthcare Reform: 26 September 2022

Stakeholders emphasize the need to ensure final surprise medical billing rules protect consumers during the arbitration process; hospitals exploit a discount drug program to mark up life-saving drugs; Medicare Advantage plans spend less on low-value care than traditional Medicare; and, hundreds of healthcare organizations urge lawmakers to extend COVID telehealth flexibilities.

Last Week in Healthcare Reform: 19 September 2022

Stakeholders emphasize the need to ensure final surprise medical billing rules protect consumers during the arbitration process; hospitals exploit a discount drug program to mark up life-saving drugs; Medicare Advantage plans spend less on low-value care than traditional Medicare; and, hundreds of healthcare organizations urge lawmakers to extend COVID telehealth flexibilities.

Last Week in Healthcare Reform: 12 September 2022

A new study links private equity investments to higher costs; drugmakers profit from donations to patient charities; Medicare Advantage continues to grow; and, a reminder of the critical role that the Medicaid program has played during the ongoing coronavirus public health crisis.

Last Week in Healthcare Reform: 29 August 2022

Final rules protecting consumers from surprise medical bills are released; employer healthcare costs are projected to rise; the majority of hospitals still fail to comply with federal price transparency requirements; and, the Medicaid program has become a vital safety net for rural communities.

Last Week in Healthcare Reform: 22 August 2022

Newly-launched prescription drugs head towards record-high prices; new research details the impact of hospital consolidation on prices and quality; private equity interests leave vulnerable rural communities exposed; and, Medicare Advantage helps millions of Americans overcome barriers.